{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:42:29Z","timestamp":1790217749793,"version":"4.1.0"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00798","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T02:46:32Z","timestamp":1541126792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":83,"title":["Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead"],"prefix":"10.3389","volume":"12","author":[{"given":"Petr","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kontsekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Zilka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jalz.2015.06.1884","article-title":"A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer\u2019s disease.","volume":"11","author":"Agadjanyan","year":"2015","journal-title":"Alzheimers Dement"},{"key":"B2","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde.","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allgemeine Z. Psychiatr. Psychisch Gerichtliche Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1073\/pnas.1322614111","article-title":"Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.","volume":"111","author":"Arif","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration.","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ajpath.2016.06.008","article-title":"High-molecular-weight paired helical filaments from alzheimer brain induces seeding of wild-type mouse Tau into an Argyrophilic 4R Tau Pathology in vivo.","volume":"186","author":"Audouard","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00262","article-title":"Tau structures.","volume":"8","author":"Avila","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention.","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"B8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","article-title":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective.","volume":"11","author":"Baumgart","year":"2015","journal-title":"Alzheimers Dement"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease.","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","article-title":"Tau, tangles, and Alzheimer\u2019s disease.","volume":"1739","author":"Binder","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease.","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-011-0908-x","article-title":"An experimental rat model of sporadic Alzheimer\u2019s disease and rescue of cognitive impairment with a neurotrophic peptide.","volume":"123","author":"Bolognin","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization.","volume":"212","author":"Bournazos","year":"2015","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","article-title":"A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.","volume":"87","author":"Braak","year":"1994","journal-title":"Acta Neuropathol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","article-title":"The pathological process underlying Alzheimer\u2019s disease in individuals under thirty.","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2006-9S305","article-title":"Vulnerability of cortical neurons to Alzheimer\u2019s and Parkinson\u2019s diseases.","volume":"9","author":"Braak","year":"2006","journal-title":"J Alzheimers Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","article-title":"Human secreted tau increases amyloid-beta production.","volume":"36","author":"Bright","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1302064","article-title":"Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling.","volume":"192","author":"Britanova","year":"2014","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain.","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1911-2","article-title":"Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.","author":"Courade","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/jsbi.2000.4270","article-title":"Abnormal tau-containing filaments in neurodegenerative diseases.","volume":"130","author":"Crowther","year":"2000","journal-title":"J. Struct. Biol."},{"key":"B23","article-title":"Pan-Tau Antibody Biib076 exhibits promising safety and biomarker profile in cynomolgus monkey toxicity study.","volume":"13","author":"Czerkovicz","year":"2018","journal-title":"Alzheimers Dementia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.vaccine.2017.03.020","article-title":"MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.","volume":"35","author":"Davtyan","year":"2017","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"B47","DOI":"10.1016\/j.vaccine.2015.02.031","article-title":"Challenges in early clinical development of adjuvanted vaccines.","volume":"33","author":"Della Cioppa","year":"2015","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","article-title":"Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).","volume":"45","author":"Dickson","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","article-title":"Extracellular monomeric and aggregated Tau efficiently enter human neurons through overlapping but distinct pathways.","volume":"22","author":"Evans","year":"2018","journal-title":"Cell Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold.","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.neurobiolaging.2010.10.015","article-title":"First transgenic rat model developing progressive cortical neurofibrillary tangles.","volume":"33","author":"Filipcik","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease.","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JAD-2012-121354","article-title":"Methods for measuring tau pathology in transgenic mouse models.","volume":"33","author":"Forest","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113111","article-title":"Age-related changes of adaptive and neuropsychological features in persons with down syndrome.","volume":"9","author":"Ghezzo","year":"2014","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease.","volume":"41","author":"G\u00f3mez-Isla","year":"1997","journal-title":"Ann. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants.","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1590\/S1980-57642009DN30100002","article-title":"Argyrophilic grain disease: an update about a frequent cause of dementia.","volume":"3","author":"Grinberg","year":"2009","journal-title":"Dement Neuropsychol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.1163581","article-title":"Tight regulation of unstructured proteins: from transcript synthesis to protein degradation.","volume":"322","author":"Gsponer","year":"2008","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","article-title":"Two novel Tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce Tau protein pathology.","volume":"288","author":"Gu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.20160833","article-title":"Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice.","volume":"213","author":"Guo","year":"2016","journal-title":"J. Exp. Med."},{"key":"B41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease.","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.08.010","article-title":"Differences in structure and function between human and murine tau.","author":"Hernandez","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.20203","article-title":"Clinicopathological correlates in frontotemporal dementia.","volume":"56","author":"Hodges","year":"2004","journal-title":"Ann. Neurol."},{"key":"B44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","article-title":"Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome. Quantitative regional analysis and comparison with Alzheimer\u2019s disease.","volume":"52","author":"Hof","year":"1995","journal-title":"Arch. Neurol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9440(10)63462-1","article-title":"Nitration of tau protein is linked to neurodegeneration in tauopathies.","volume":"163","author":"Horiguchi","year":"2003","journal-title":"Am. J. Pathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far.","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic Tau in Alzheimer\u2019s Disease.","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"B48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00401-006-0156-7","article-title":"Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.","volume":"113","author":"Jellinger","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1750-3639.1998.tb00160.x","article-title":"Senile dementia with tangles (tangle predominant form of senile dementia).","volume":"8","author":"Jellinger","year":"1998","journal-title":"Brain Pathol."},{"key":"B51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","article-title":"Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.","volume":"48","author":"Jicha","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","article-title":"Neuropathological background of phenotypical variability in frontotemporal dementia.","volume":"122","author":"Josephs","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","article-title":"Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.","volume":"66","author":"Josephs","year":"2006","journal-title":"Neurology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2012.06.003","article-title":"Axonal degeneration in Alzheimer\u2019s disease: when signaling abnormalities meet the axonal transport system.","volume":"246","author":"Kanaan","year":"2013","journal-title":"Exp. Neurol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1523\/JNEUROSCI.22-03-00698.2002","article-title":"Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau.","volume":"22","author":"Klein","year":"2002","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model.","volume":"6","author":"Kontsekova","year":"","journal-title":"Alzheimers Res. Ther."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt277","article-title":"Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer\u2019s disease.","volume":"6","author":"Kontsekova","year":"","journal-title":"Alzheimers Res. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneumeth.2008.09.027","article-title":"NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy.","volume":"177","author":"Korenova","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1460-9568.2008.06329.x","article-title":"Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.","volume":"28","author":"Koson","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.4049\/jimmunol.1100216","article-title":"Misfolded truncated protein tau induces innate immune response via MAPK pathway.","volume":"187","author":"Kovac","year":"2011","journal-title":"J. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000283478","article-title":"Transition of tau protein from disordered to misordered in Alzheimer\u2019s disease.","volume":"7","author":"Kovacech","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"B62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jemt.20188","article-title":"Characterization of paired helical filaments by scanning transmission electron microscopy.","volume":"67","author":"Ksiezak-Reding","year":"2005","journal-title":"Microsc. Res. Tech."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"B64","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1016\/S0021-9258(17)31849-5","article-title":"Analysis of microtubule-associated protein tau glycation in paired helical filaments.","volume":"269","author":"Ledesma","year":"1994","journal-title":"J. Biol. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.celrep.2016.06.099","article-title":"Antibody-mediated targeting of tau in vivo does not require effector function and microglial engagement.","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep."},{"key":"B66","first-page":"61","article-title":"The differential diagnosis and treatment of atypical parkinsonism.","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"key":"B67","doi-asserted-by":"publisher","first-page":"E3755","DOI":"10.1073\/pnas.1600953113","article-title":"Tau protein is essential for stress-induced brain pathology.","volume":"113","author":"Lopes","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","article-title":"Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging.","volume":"38","author":"Maass","year":"2018","journal-title":"J. Neurosci."},{"key":"B69","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.neurobiolaging.2013.01.017","article-title":"Variation in tau isoform expression in different brain regions and disease states.","volume":"34","author":"Majounie","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1084\/jem.20161731","article-title":"Tau deletion promotes brain insulin resistance.","volume":"214","author":"Marciniak","year":"2017","journal-title":"J. Exp. Med."},{"key":"B71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy.","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"B72","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.neuron.2015.01.025","article-title":"Pathological tau disrupts ongoing network activity.","volume":"85","author":"Menkes-Caspi","year":"2015","journal-title":"Neuron"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s00018-016-2216-z","article-title":"Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding.","volume":"73","author":"M\u00e9phon-Gaspard","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/srep05715","article-title":"Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons.","volume":"4","author":"Mohamed","year":"2014","journal-title":"Sci. Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuroscience.2010.05.022","article-title":"Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer\u2019s disease.","volume":"169","author":"Morawski","year":"2010","journal-title":"Neuroscience"},{"key":"B76","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.3029875","article-title":"Ubiquitin is a component of paired helical filaments in Alzheimer\u2019s disease.","volume":"235","author":"Mori","year":"1987","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/joim.12199","article-title":"Harmonized diagnostic criteria for Alzheimer\u2019s disease: recommendations.","volume":"275","author":"Morris","year":"2014","journal-title":"J. Intern. Med."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","article-title":"Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum.","volume":"138","author":"Murray","year":"2015","journal-title":"Brain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ajpath.2017.01.022","article-title":"Tau antibody targeting pathological species blocks neuronal uptake and interneuron propagation of Tau in vitro.","volume":"187","author":"Nobuhara","year":"2017","journal-title":"Am. J. Pathol."},{"key":"B82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/j.1460-2075.1993.tb05665.x","article-title":"Molecular characterization of the minimal protease resistant tau unit of the Alzheimer\u2019s disease paired helical filament.","volume":"12","author":"Novak","year":"1993","journal-title":"EMBO J."},{"key":"B83","article-title":"FUNDAMANT: an interventional 72-week phase 1 follow study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease.","author":"Novak","year":"","journal-title":"Alzheimers Res. Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"S535","DOI":"10.3233\/JAD-179942","article-title":"Tau conformation as a target for disease-modifying therapy: the role of truncation.","volume":"64","author":"Novak","year":"","journal-title":"J. Alzheimers Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-2011-110194","article-title":"Tauons and prions: infamous cousins?","volume":"26","author":"Novak","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","article-title":"Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 1 trial.","volume":"16","author":"Novak","year":"2017","journal-title":"Lancet Neurol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02926-5","article-title":"A transcriptomic atlas of aged human microglia.","volume":"9","author":"Olah","year":"2018","journal-title":"Nat. Commun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3233\/JAD-2012-121072","article-title":"Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.","volume":"33","author":"Opattova","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-140996","article-title":"N-terminal truncation of microtubule associated protein tau dysregulates its cellular localization.","volume":"43","author":"Paholikova","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B90","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"B91","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","article-title":"Tau is a candidate gene for chromosome 17 frontotemporal dementia.","volume":"43","author":"Poorkaj","year":"1998","journal-title":"Ann. Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines.","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"B93","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.parkreldis.2015.09.041","article-title":"The phenotypic spectrum of progressive supranuclear palsy.","volume":"22","author":"Respondek","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B94","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1073\/pnas.1203140109","article-title":"Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation.","volume":"109","author":"Rissman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awu190","article-title":"Perforant path synaptic loss correlates with cognitive impairment and Alzheimer\u2019s disease in the oldest-old.","volume":"137","author":"Robinson","year":"2014","journal-title":"Brain"},{"key":"B96","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/nlw034","article-title":"Argyrophilic grain disease: demographics, clinical, and neuropathological features from a large autopsy study.","volume":"75","author":"Rodriguez","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1002\/jnr.21721","article-title":"wo motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.","volume":"86","author":"Sarkar","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B98","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuron.2018.04.035","article-title":"Tau Kinetics in Neurons and the Human Central Nervous System.","volume":"98","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00580","article-title":"Advances in therapeutic Fc engineering - modulation of IgG-associated effector functions and serum half-life.","volume":"7","author":"Saxena","year":"2016","journal-title":"Front. Immunol."},{"key":"B100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2567.1999.00845.x","article-title":"Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites.","volume":"97","author":"Schuurman","year":"1999","journal-title":"Immunology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00702-011-0649-y","article-title":"Fronto-temporal lobar degeneration: neuropathology in 60 cases.","volume":"118","author":"Seilhean","year":"2011","journal-title":"J. Neural. Transm."},{"key":"B102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as a differential biomarker of tauopathies.","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B103","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","article-title":"The genetics and neuropathology of frontotemporal lobar degeneration.","volume":"124","author":"Sieben","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age.","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-161124","article-title":"Neuronal expression of truncated tau efficiently promotes neurodegeneration in animal models: pitfalls of toxic oligomer analysis.","volume":"58","author":"Skrabana","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tins.2013.12.001","article-title":"The human side of microglia.","volume":"37","author":"Smith","year":"2014","journal-title":"Trends Neurosci."},{"key":"B107","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration.","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"c83","DOI":"10.1159\/000324758","article-title":"Survival analysis I: the Kaplan-Meier method.","volume":"119","author":"Stel","year":"2011","journal-title":"Nephron Clin. Pract."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-64","article-title":"Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer\u2019s disease.","volume":"7","author":"Stozicka","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease.","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B111","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-014-0142-6","article-title":"Microglial pathology.","volume":"2","author":"Streit","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.coi.2014.05.005","article-title":"Human CNS immune senescence and neurodegeneration.","volume":"29","author":"Streit","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","article-title":"The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.","volume":"181","author":"Tai","year":"2012","journal-title":"Am. J. Pathol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-160695","article-title":"Novel phospho-tau monoclonal antibody generated using a liposomal vaccine, with enhanced recognition of a conformational tauopathy epitope.","volume":"56","author":"Theunis","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy.","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/cen3.12307","article-title":"Microglia communication: Parallels between aging and Alzheimer\u2019s disease.","volume":"7","author":"Udeochu","year":"2016","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"B117","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00308476","article-title":"A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease.","volume":"83","author":"Vallet","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B118","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/21637","article-title":"A stop-codon mutation in the BRI gene associated with familial British dementia.","volume":"399","author":"Vidal","year":"1999","journal-title":"Nature"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions.","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"B120","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/bi052530j","article-title":"The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.","volume":"45","author":"von Bergen","year":"2006","journal-title":"Biochemistry"},{"key":"B121","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B122","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm0896-871","article-title":"Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer\u2019s disease.","volume":"2","author":"Wang","year":"1996","journal-title":"Nat. Med."},{"key":"B123","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology.","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4827","article-title":"Clinical review. Frontotemporal dementia.","volume":"347","author":"Warren","year":"2013","journal-title":"BMJ"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models.","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"key":"B126","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly.","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B127","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.","volume":"231","author":"West","year":"1991","journal-title":"Anat. Rec."},{"key":"B128","doi-asserted-by":"publisher","first-page":"236","DOI":"10.14283\/jpad.2017.36","article-title":"Preclinical and clinical development of ABBV-8E12, a humanized anti-tau antibody, for treatment of alzheimer\u2019s disease and other tauopathies.","volume":"4","author":"West","year":"2017","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer\u2019s disease: randomised, double-blind, placebo-controlled, first-in-human study.","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"key":"B130","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","article-title":"Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.","volume":"85","author":"Wischik","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147733","article-title":"A comprehensive behavioral test battery to assess learning and memory in 129S6\/Tg2576 mice.","volume":"11","author":"Wolf","year":"2016","journal-title":"PLoS One"},{"key":"B132","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-1-30","article-title":"Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).","volume":"1","author":"Wszolek","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","article-title":"Neuronal activity regulates extracellular tau in vivo.","volume":"211","author":"Yamada","year":"2014","journal-title":"J. Exp. Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/acn3.176","article-title":"Anti-tau antibody reduces insoluble tau and decreases brain atrophy.","volume":"2","author":"Yanamandra","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/j.1471-4159.2009.05882.x","article-title":"Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases.","volume":"108","author":"Yu","year":"2009","journal-title":"J. Neurochem."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00027","article-title":"Relevance of phosphorylation and truncation of tau to the etiopathogenesis of Alzheimer\u2019s disease.","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B137","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","article-title":"Truncated tau from sporadic Alzheimer\u2019s disease suffices to drive neurofibrillary degeneration in vivo.","volume":"580","author":"Zilka","year":"2006","journal-title":"FEBS Lett."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-47","article-title":"Who fans the flames of Alzheimer\u2019s disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways.","volume":"9","author":"Zilka","year":"","journal-title":"J. Neuroinflammation"},{"key":"B139","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/BST20120015","article-title":"The self-perpetuating tau truncation circle.","volume":"40","author":"Zilka","year":"","journal-title":"Biochem. Soc. Trans."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00798\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T22:49:27Z","timestamp":1662331767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00798\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":139,"alternative-id":["10.3389\/fnins.2018.00798"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00798","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"article-number":"798"}}